STOCK TITAN

Decoy Therapeutics Inc. (DCOY) Free Cash Flow by Year

DCOY

Decoy Therapeutics Inc. recorded an outflow of $5.4M in free cash flow in fiscal year 2025. This represents a decrease of 19.4% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Decoy Therapeutics Inc. has filed alongside them.

FY2025 annual
Free Cash Flow -$5.4M
YoY -19.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

DCOY Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
Free Cash Flow-$5.4M-19.4%-$4.5MN/AN/A-$10.2M+1.1%-$10.3M+10.9%-$11.6M-377.2%$4.2M+115.0%-$27.8M+14.6%-$32.6M-55.2%-$21.0M

DCOY Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Free Cash FlowN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Decoy Therapeutics Inc. financials

Frequently Asked Questions

What was Decoy Therapeutics Inc.'s free cash flow in fiscal year 2025?

Decoy Therapeutics Inc. recorded an outflow of $5.4M in free cash flow in fiscal year 2025.

How fast is Decoy Therapeutics Inc.'s free cash flow growing?

Decoy Therapeutics Inc. (DCOY) free cash flow fell by 19.4% year over year, from -$4.5M to -$5.4M in fiscal year 2025.

How has Decoy Therapeutics Inc.'s free cash flow changed over the years?

Across the 11 fiscal years this page covers, Decoy Therapeutics Inc. (DCOY) free cash flow went from -$21.0M in fiscal year 2015 to -$5.4M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Decoy Therapeutics Inc. (DCOY) reported on that line in every period on record.